Author

Olayinka T Adebola

Professor of Medical Microbiology, Ahmadu Bello University, Nihgeria - Cited by 2,282 - Infectious diseases

Biography

 Dr Adebola Olayinka is a Clinical Microbiologist in Ahmadu Bello University & Teaching Hospital, Zaria. She completed her Masters in Ahmadu Bello University, Zaria ( Masters of Public health). She completed her bachelors in University of Ilorin, Kwara State, Nigeria. She is expertise in Clinical research and Infectious Diseases. Her research field includes in Immunology, Molecular Biology,  Microbiology, infectious diseases, epidemology.  
Title
Cited by
Year
Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries
Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ...The Lancet Global Health 7 (7), e861-e871, 2019201
205
2019
Nigeria’s public health response to the COVID-19 pandemic: January to May 2020
C Dan-Nwafor, CL Ochu, K Elimian, J Oladejo, E Ilori, C Umeokonkwo, ...Journal of global health 10 (2), 2020202
102
2020
Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February–6 June 2020
KO Elimian, CL Ochu, E Ilori, J Oladejo, E Igumbor, L Steinhardt, J Wagai, ...Epidemiology & Infection 148, e208, 2020202
62
2020
Assessment of hand hygiene facilities and staff compliance in a large tertiary health care facility in northern Nigeria: a cross sectional study
KI Onyedibe, NY Shehu, D Pires, SE Isa, MO Okolo, SS Gomerep, ...Antimicrobial Resistance & Infection Control 9, 1-9, 2020202
47
2020
A systematic review on the prevalence of extended-spectrum beta lactamase-producing Gram-negative bacteria in Nigeria
N Tanko, RO Bolaji, AT Olayinka, BO OlayinkaJournal of Global Antimicrobial Resistance , 488-496, 2020202
22
2020
Evaluation of knowledge and awareness of invasive fungal infections amongst resident doctors in Nigeria
R Oladele, AA Otu, O Olubamwo, OB Makanjuola, EA Ochang, J Ejembi, ...Pan African Medical Journal 36 (1), 2020202
18
2020
Epidemiology and case-control study of Lassa fever outbreak in Nigeria from 2018 to 2019
O Ipadeola, Y Furuse, EA Ilori, CC Dan-Nwafor, KO Akabike, A Ahumibe, ...Journal of Infection 80 (5), 578-606, 2020202
16
2020
Introduction of mobile health tools to support COVID-19 training and surveillance in Ogun State Nigeria
A Otu, O Okuzu, B Ebenso, E Effa, N Nihalani, A Olayinka, S YayaFrontiers in Sustainable Cities 3, 638278, 2021202
12
2021
Prioritization of zoonotic diseases of public health significance in Nigeria using the one-health approach
C Ihekweazu, CA Michael, PM Nguku, NE Waziri, AG Habib, M Muturi, ...One Health 13, 100257, 2021202
11
2021
Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10–11 September 2019
Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10– September 2019K Salami, PS Gsell, A Olayinka, D Maiga, P Formenty, PG Smith, ...Vaccine 38 (26), 4135-4141, 2020202
11
2020
Training health workers at scale in Nigeria to fight COVID-19 using the InStrat COVID-19 tutorial app: an e-health interventional study
A Otu, O Okuzu, E Effa, B Ebenso, S Ameh, N Nihalani, O Onwusaka, ...Therapeutic Advances in Infectious Disease , 20499361211040704, 2021202
8
2021
Underutilization of the clinical microbiology laboratory by physicians in Nigeria
KC Iregbu, CS Osuagwu, CD Umeokonkwo, AA Fowotade, OI Ola-Bello, ...African Journal of Clinical and Experimental Microbiology 21 (1), 53-59, 2020202
7
2020
Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study
NL Chandra, H Bolt, C Dan-Nwafor, O Ipadeola, E Ilori, G Namara, ...BMC infectious diseases 21 (1), 1-11, 2021202
6
2021
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever
AT Olayinka, J Bourner, GO Akpede, J Okoeguale, C Abejegah, NA Ajayi, ...PLoS Neglected Tropical Diseases 16 (1), e0010089, 2022202
5
2022
Antimicrobial prescription pattern in a tertiary hospital
AT Olayinka, O Jimoh, J Ejembi, OT Ige, Z Lamido, A Ibrahim, V Aganabor, ...Sahel Medical Journal 23 (2), 103, 2020202
5
2020
The 2021 cholera outbreak in West Africa: epidemiology and public health implications
VD Sodjinou, A Talisuna, F Braka, P Barboza, K Alberti, A FORTIN, ...Archives of Clinical and Biomedical Research 6 (2), 296-307, 2022202
4
2022
Awareness and use of folic acid among women of childbearing age in Benue State, Nigeria
UA Okon, BS Ibrahim, R Usman, E Adedire, MS Balogun, A OlayinkaPan African Medical Journal 37 (1), 2020202
4
2020
Assessing the capacity of symptom scores to predict COVID-19 positivity in Nigeria: a national derivation and validation cohort study
KO Elimian, O Aderinola, J Gibson, P Myles, CL Ochu, C King, T Okwor, ...BMJ open 11 (9), e09699, 2021202
4
2021
The One Health approach to incident management of the 2019 Lassa fever outbreak response in Nigeria
CD Nwafor, E Ilori, A Olayinka, C Ochu, R Olorundare, E Edeh, T Okwor, ...One Health 13, 10036, 2021202
4
2021
HIV-Malaria co-infection and its determinants among patients attending antiretroviral treatment clinic in Zaria
SD Gumel, A Ibrahim, AT Olayinka, MS Ibrahim, MS Balogun, A DahiruKaduna state, Nigeria J Interval Epidemiol Public Health 4 (1), 2, 2021202
3
2021

Referred From: https://scholar.google.com/citations?user=UsOF3CwAAAAJ&hl=en

Cited by
Citations 2282
h-index 24
i10-index 51
Recommended Journals
Open Access Journals